Our Mission

Ossium’s mission is to improve human health. We will deploy cellular therapeutics, bioengineering, and other regenerative medical tools to produce lasting gains in the health, vitality, and longevity of human beings. In pursuit of these goals, we will foster a culture that empowers our stakeholders, maintain the highest standards of operational excellence, and be a force for good.

Our Vision

Ossium’s vision is a future in which scientific progress enables humans to live without disease.

Ossium Leadership

Kevin Caldwell, Esq.
Co-Founder, President & CEO
Dr. Erik Woods
Co-Founder, Chief Science Officer

Ossium Team

Dr. W. Scott Goebel
Medical Director
Dr. Margie Mathewson
Vice President of Business Operations
Dr. Brian Johnstone
Sr. Director of Research and Development
Dr. Matthew Metz
Director of Strategic Partnerships
Oliver Cacananta
Director of Regulatory Affairs
Jonathon Rochelle
Director of Quality Systems
Dr. Dongsheng Gu
Senior Scientist
Aubrey Sherry, MS
CLIA Laboratory Technical Supervisor & Project Manager
Kelsey Musall
Cellular Laboratory Production Supervisor
Karina Chavarria, MA
Donor Manager
Abegail Brar
Donor Manager
Hannah Miller, MS
Cellular Therapy Technologist II
Tracie Dehart
Quality Assurance Specialist
Joyce Abad
Document Coordinator
Katlynn McCray
Cellular Therapy Associate I
Estivan Carreon
Cellular Therapy Associate I
Jeffrey Tippin
Cellular Therapy Associate I
Megan Sannito
Cellular Therapy Associate I
Sara Brown
Cellular Therapy Associate I
Kenneth McGraw
Cellular Therapy Associate I
Nyla Haddock
Cellular Therapy Associate I
Darian Flores
Cellular Therapy Associate

Ossium Advisors

Dr. James Peyer
Scientific Advisor
Jesse Horwitz
Business Advisor
Tim Abbott, MS
Business Advisor


To raise new questions, new possibilities, to regard old problems from a new angle,

requires creative imagination and marks real advance in science.

– Albert Einstein